About Medical Male Circumcision
This fact sheet provides basic information
on medical male circumcision, an HIV
risk-reduction strategy that has shown efficacy
and is being introduced for HIV-negative men.
For in-depth coverage of male circumcision for
HIV prevention, please visit the Clearinghouse on Male
Circumcision for HIV Prevention, a
collaborative effort of AVAC, WHO/UNAIDS and
FHI to generate and share information resources
with the international public health community,
civil society groups, health policy makers, and
programme managers.
You can also
download the information on this page as a male
circumcision fact sheet (PDF).
What is medical male
circumcision?
Medical male circumcision is the removal of all or part of the foreskin of the penis by a trained health professional. The term medical male circumcision differentiates circumcision that is performed by a trained health professional from traditional circumcision, which is performed as part of a religious ritual or cultural rite of passage.
How did we learn that male circumcision works to help prevent HIV?
Male circumcision for HIV prevention was evaluated in three large-scale randomized controlled clinical trials that enrolled in total about 10,000 men in Kenya, Uganda, and South Africa. Each of these trials used surgical techniques that had proven safe and effective over years of use in other contexts. Each participant received a standard prevention package including treatment for sexually transmitted infections, condoms, and behavior change counseling. Some of the participants were randomly assigned to the experimental group, in which they received circumcision during the trial. Other participants were assigned to the control group and were asked to remain uncircumcised throughout the study. All participants were counseled at every study visit that they couldn't assume they would be protected. Over the course of the trial period, some participants got infected even though they were being counseled and receiving prevention services. This is consistent with what we know about the AIDS epidemic: even with information and services, not everyone can protect himself or herself all the time.
In the trials, participants who received
circumcision plus the prevention package were
estimated to have 60 percent fewer infections
than those in the control group (who received
the prevention package alone). Rates of condom
use and risk behaviors were similar between the
circumcised and uncircumcised groups. This led
researchers to conclude that circumcision
provided risk reduction beyond that provided by
standard prevention (i.e., STI treatment,
condoms and counseling).
Why does male
circumcision work as an HIV prevention
method?
There is no definite answer
to why medical male circumcision reduces men's
risk of HIV infection during vaginal sex, but
there are several possible explanations. The
foreskin of the penis has many cells of a type
that are vulnerable to HIV infection. Removing
the foreskin removes these "target cells" and
makes the penile skin more durable, which might
also reduce risk. Medical male circumcision
also reduces the rate of genital ulcer disease.
Genital ulcers can increase the risk of HIV
infection.
When did male circumcision research
take place?
Clinical studies to
determine male circumcision's safety and
efficacy in reducing risk of HIV transmission
were undertaken between 2005 and 2007. A trial
conducted in Orange Farm, South Africa found a
50 percent reduction in men's risk of HIV
infection and released these data in 2005.
Ugandan and Kenyan trials released similar
findings in late 2006. Based on this evidence,
WHO and UNAIDS issued a 2007 guidance document
recognizing male circumcision as an additional
important intervention to reduce the risk of
heterosexually acquired HIV infection in men.
The WHO/UNAIDS guidance document on male
circumcision for HIV prevention states that the
service should be offered along with HIV
testing and counseling services, treatment for
sexually transmitted infections, the promotion
of safer-sex practices, and the provision of
male and female condoms.
Where did male circumcision trials
take place and where is it currently being
rolled out?
Three trials in
HIV-negative men in Kenya, South Africa, and
Uganda were completed, and these trial sites
are also expanding male circumcision services
to the broader community.
Now that the trials are completed and there
is guidance from the WHO, many countries are
considering introducing male circumcision as
part of their prevention programs. The pace and
the stage of effort vary among these countries.
The WHO is tracking the progress in male
circumcision scale-up. Visit http://www.malecircumcision.org/
to download the latest country implementation
update.
Who will benefit from
male circumcision research?
Medical
male circumcision reduces heterosexual men's
risk of getting HIV from female partners. There
may eventually be benefits to women if male
circumcision coverage increases to where it
reduces the number of HIV-positive men. Some researchers have predicted
that if male circumcision were to become
widespread in sub-Saharan Africa, almost 6
million infections would be prevented over 20
years, as would 3 million deaths among both men
and women.
Much more information is needed about male circumcision and its impact on women and their ability to negotiate condom use and shared sexual decision-making. For more information on the implications for women, please visit the Male Circumcision and Women page at the Clearinghouse on Male Circumcision.
It remains unclear whether medical male circumcision could have an impact on HIV transmission among gay men and other men who have sex with men. A meta-analysis of available data found insufficient evidence of circumcision's protective effect in MSM. However, recent findings show that circumcision might help reduce transmission in MSM who report a preference for the insertive sexual role.
AVAC is currently supporting women's
community-based efforts to monitor, evaluate,
and develop or expand advocacy around new and
emerging HIV prevention strategies via the
Women's HIV Prevention Tracking Project
(WHiPT). There are currently WHiPT teams
receiving support for pilot projects tracking
the implications for women of the introduction
of male circumcision for HIV prevention. Visit
the WHiPT
page for more information.
For more information on medical male
circumcision, go to the Male
Circumcision Clearinghouse and read AVAC's
report, A New Way to Protect Against
HIV? Understanding the Results of Male
Circumcision Studies for HIV
Prevention.
Visit the HIV
prevention research timeline and trials
map for details on other ongoing biomedical
HIV prevention research trials.
Click here for more information on medical
male circumcision trials.




